DEA “likely” to reschedule cannabis, congressional researchers say (Newsletter: September 15, 2023)
WH touts Biden marijuana moves; Senators talk SAFE Banking; RFK Jr. on cannabis; NE ballot
Santa Barbara’s wine industry declared war on weed. Pot is winning.
They might not be profitable yet, but California’s biggest pot farms are here to stay
FDA, CDC And Other Federal Agencies Discuss Marijuana Research Barriers, State Legalization Models And CBD Regulations At National Academies Meeting
Representatives of multiple federal agencies participated in a National Academies of Sciences, Engineering and Medicine
High Tide Revenue Increases Again, But Still Losing Money
The company met its free cash flow goal five months ahead of schedule. Canada-based High
Oklahoma Supreme Court Declines to Rule on MMJ License Fee Hike
Tiered fees were introduced to replace the previous flat rate of $2,500. The Oklahoma state
MAPS Inches Closer to Federal New Drug Application for MDMA
One of the psychedelics industry’s leading researchers, the Multidisciplinary Association for Psychedelic Studies, this week
After Latest Clinical Trial, MDMA Therapy For PTSD Is ‘On Track’ For FDA Consideration Next Year
A new peer-reviewed study in the journal Nature says treatment with MDMA reduced symptoms in
Green Market Report Michigan Awards: Top Dispensary PUFF Cannabis Co.
Puff has aspirations to become a “household name … in every state.” At the first
Maryland’s Adult-Use Cannabis Rollout Heralded as Model Success
Unlike the myriad of challenges operators in New York face, new applicants in Maryland are
The Daily Hit: September 14, 2023
The Daily Hit is a recap of the top financial news stories for Sept. 14,